Cidara Therapeutics (CDTX) Misses Q3 EPS by 310c
Tweet
Share
E-mailCidara Therapeutics (NASDAQ: CDTX) reported Q3 EPS of ($3.10).
For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Midera Food Processing and Centrus Energy to join S&P SmallCap 600
- BNP Paribas Exane Upgrades Novonesis A/S (NSISB:DC) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
